Furthermore, RNA‐seq in tumour culture supernatants from prostate cancer patients, as well as blood and urine EVs before and after resection found differential expression of reactive oxygen species, p53 pathway, inflammatory/cytokine, oncogenes and tumour suppressor genes in EV nanosatellites (Chen et al., 2022). This evidence concerns the gene TP53 and neoplasm.